Inactive Instrument

diaDexus, Inc. Stock OTC Bulletin Board

Pharmaceuticals

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

17/09/21	Diadexus, Inc. Went Out of Business	CI
08/06/18	Motion for Asset Sale Approved for Diadexus, Inc.	CI

Diadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of patients throughout the course of cardiac disease. Its capabilities include manufacturing, assay development, Food and Drug Administration (FDA) regulatory clearance, and marketing and selling products. Its commercially-available products consist of two FDA-cleared tests to measure Lp-PLA2: the PLAC Test ELISA Kit (the PLAC ELISA Test) and the PLAC Test for Lp-PLA2 Activity (the PLAC Activity Test). Its other products include proADM; proET-1, which aids in predication of heart failure, and proANP, which aids in predication of heart failure. The Company sells its diagnostic products to laboratories and promotes these products to the laboratories' sales representatives, as well as directly to healthcare providers.

Employees

Sector

Pharmaceuticals

More about the company

Market Cap	49.2K 43.15K 39.97K 36.78K 69.56K 4.71M 70.91K 476K 187K 2.31M 185K 181K 7.99M	P/E 2014	-3.26x	P/E 2015	-1.14x
Enterprise Value	5.29M 4.64M 4.3M 3.95M 7.48M 506M 7.62M 51.22M 20.09M 249M 19.87M 19.43M 859M	EV / Sales 2014	1.05x	EV / Sales 2015	0.77x
Free-Float	100%	Yield 2014 *	-	Yield 2015	-

17/09/21	Diadexus, Inc. Went Out of Business	CI
08/06/18	Motion for Asset Sale Approved for Diadexus, Inc.	CI
09/05/18	Motion for Asset Sale Filed by Diadexus, Inc.	CI
01/08/16	Diazyme Laboratories, Inc. completed the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
29/07/16	Motion for Asset Sale Approved for Diadexus, Inc.	CI
29/07/16	General Atomics Corp. entered into purchase agreement to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $4.8 million.	CI
20/07/16	Cleveland HeartLab, Inc. cancelled the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
07/07/16	Motion for Asset Sale Filed by Diadexus, Inc.	CI
07/07/16	Cleveland HeartLab, Inc. agreed to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $7 million.	CI
13/06/16	Diadexus, Inc. Filed for Bankruptcy	CI
11/06/16	Diadexus, Inc. Announces Resignation of Leone Patterson as Chief Financial Office	CI
23/05/16	Diadexus, Sonic Healthcare USA Sign National Agreement for PLAC Activity Test	CI
30/04/16	Diadexus, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2016	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ULTRAGENYX PHARMACEUTICAL INC.	-1.77%	-1.42%	+12.57%	-24.79%	3.26B
SAREPTA THERAPEUTICS, INC.	-0.69%	-1.88%	+3.58%	-82.65%	1.99B
BIONOTE, INC.	-2.86%	-2.03%	-12.76%	-16.42%	310M
DK LIFE SCIENCE CO., LTD.	-4.05%	-4.82%	-47.57%	-	50.76M
Average	-2.34%	-2.42%	-11.04%	-41.29%	1.4B
Weighted average by Cap.	-1.47%	-1.64%	+7.44%	-45.01%

	2014	2015
Net sales	26.11M 22.9M 21.21M 19.52M 36.92M 2.5B 37.64M 253M 99.16M 1.23B 98.05M 95.91M 4.24B	17.88M 15.69M 14.53M 13.37M 25.28M 1.71B 25.78M 173M 67.91M 841M 67.16M 65.69M 2.9B
Net income	-8.47M -7.43M -6.88M -6.33M -11.97M -810M -12.2M -81.98M -32.15M -398M -31.79M -31.1M -1.37B	-7.17M -6.29M -5.82M -5.36M -10.13M -686M -10.33M -69.38M -27.21M -337M -26.91M -26.32M -1.16B
Net Debt	-198K -174K -161K -148K -280K -18.95M -285K -1.92M -752K -9.31M -744K -727K -32.14M	5.24M 4.6M 4.26M 3.92M 7.41M 502M 7.55M 50.74M 19.9M 246M 19.68M 19.25M 851M

diaDexus, Inc. Stock OTC Bulletin Board

Stocks

Pharmaceuticals

Valuation: diaDexus, Inc.

Latest news : diaDexus, Inc.

Diagnostic & Testing Substances Manufacturers

Financials

Company Profile